T2 Biosystems, Inc.
TTOO · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $35 | $76 | $15 | $31 |
| - Cash | $2 | $4 | $6 | $16 |
| + Debt | $19 | $19 | $49 | $49 |
| Enterprise Value | $52 | $91 | $58 | $65 |
| Revenue | $2 | $2 | $2 | $2 |
| % Growth | 1.7% | -5.3% | 22.8% | – |
| Gross Profit | -$2 | -$1 | -$2 | -$1 |
| % Margin | -106.6% | -38% | -103.9% | -57.7% |
| EBITDA | -$10 | -$8 | -$12 | -$9 |
| % Margin | -488.1% | -431.5% | -596.4% | -542.3% |
| Net Income | -$10 | -$9 | -$14 | -$10 |
| % Margin | -509.7% | -459.2% | -656.7% | -615.8% |
| EPS Diluted | -0.57 | -0.64 | -2.66 | -2.08 |
| % Growth | 10.9% | 75.9% | -27.9% | – |
| Operating Cash Flow | -$6 | -$9 | -$12 | -$9 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$6 | -$9 | -$12 | -$9 |